Bank of America’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-19
| Closed | -$91 | – | 8323 |
|
|
2025
Q3 | $91 | Buy |
19
+1
| +6% | +$4 | ﹤0.01% | 7877 |
|
|
2025
Q2 | $75 | Hold |
18
| – | – | ﹤0.01% | 8028 |
|
|
2025
Q1 | $64 | Buy |
18
+1
| +6% | +$4 | ﹤0.01% | 7923 |
|
|
2024
Q4 | $55 | Hold |
17
| – | – | ﹤0.01% | 7848 |
|
|
2024
Q3 | $89 | Hold |
17
| – | – | ﹤0.01% | 7739 |
|
|
2024
Q2 | $95 | Buy |
17
+5
| +42% | +$34 | ﹤0.01% | 7714 |
|
|
2024
Q1 | $86 | Buy |
12
+2
| +20% | +$14 | ﹤0.01% | 7412 |
|
|
2023
Q4 | $85 | Hold |
10
| – | – | ﹤0.01% | 7432 |
|
|
2023
Q3 | $97 | Hold |
10
| – | – | ﹤0.01% | 7469 |
|
|
2023
Q2 | $133 | Hold |
10
| – | – | ﹤0.01% | 7406 |
|
|
2023
Q1 | $170 | Hold |
10
| – | – | ﹤0.01% | 7443 |
|
|
2022
Q4 | $161 | Hold |
10
| – | – | ﹤0.01% | 7590 |
|
|
2022
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 8204 |
|
|
2022
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 8389 |
|
|
2022
Q1 | $0 | Sell |
10
-1
| -9% | -$21 | ﹤0.01% | 8763 |
|
|
2021
Q4 | $0 | Buy |
11
+1
| +10% | +$30 | ﹤0.01% | 8643 |
|
|
2021
Q3 | $0 | Sell |
10
-4
| -29% | -$175 | ﹤0.01% | 8397 |
|
|
2021
Q2 | $1K | Buy |
14
+7
| +100% | +$350 | ﹤0.01% | 7651 |
|
|
2021
Q1 | $0 | Sell |
7
-296
| -98% | -$19.6K | ﹤0.01% | 7776 |
|
|
2020
Q4 | $20K | Buy |
303
+293
| +2,930% | +$23.2K | ﹤0.01% | 6590 |
|
|
2020
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 6794 |
|
|
2020
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 6684 |
|
|
2020
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 6739 |
|
|
2019
Q4 | $1K | Sell |
10
-3
| -23% | -$361 | ﹤0.01% | 6981 |
|
|
2019
Q3 | $2K | Buy |
13
+3
| +30% | +$1.35K | ﹤0.01% | 7016 |
|
|
2019
Q2 | $8K | Hold |
10
| – | – | ﹤0.01% | 6770 |
|
|
2019
Q1 | $11K | Hold |
10
| – | – | ﹤0.01% | 6631 |
|
|
2018
Q4 | $8K | Hold |
10
| – | – | ﹤0.01% | 6680 |
|
|
2018
Q3 | $8K | Hold |
10
| – | – | ﹤0.01% | 6730 |
|
|
2018
Q2 | $40K | Hold |
10
| – | – | ﹤0.01% | 6253 |
|
|
2018
Q1 | $39K | Hold |
10
| – | – | ﹤0.01% | 6139 |
|
|
2017
Q4 | $49K | Hold |
10
| – | – | ﹤0.01% | 6079 |
|
|
2017
Q3 | $65K | Sell |
10
-2
| -17% | -$12.4K | ﹤0.01% | 5841 |
|
|
2017
Q2 | $82K | Hold |
12
| – | – | ﹤0.01% | 5676 |
|
|
2017
Q1 | $140K | Buy |
12
+1
| +9% | +$14.1K | ﹤0.01% | 5479 |
|
|
2016
Q4 | $157K | Buy |
11
+1
| +10% | +$16.8K | ﹤0.01% | 5434 |
|
|
2016
Q3 | $222K | Hold |
10
| – | – | ﹤0.01% | 5071 |
|
|
2016
Q2 | $204K | Hold |
10
| – | – | ﹤0.01% | 5191 |
|
|
2016
Q1 | $174K | Sell |
10
-2
| -17% | -$26.7K | ﹤0.01% | 5207 |
|
|
2015
Q4 | $196K | Buy |
+12
| New | +$195K | ﹤0.01% | 5392 |
|
Other funds holding TTNP
CA
GWSA
CSC
DJSG
Bank of America's TTNP Position: Q4 2025 in Review
Bank of America sold out of Titan Pharmaceuticals (TTNP) in Q4 2025, closing a stake of 19 shares — an estimated $91 sold.
Bank of America first reported a position in TTNP in Q4 2015 and held it in 40 quarters. The position peaked at $222K in Q3 2016. 4 funds tracked by Wall St. Rank hold TTNP as of Q4 2025.
- Bank of America reported no remaining Titan Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Bank of America sold 19 Titan Pharmaceuticals shares in Q4 2025, an estimated $91.
- Bank of America first reported a position in Titan Pharmaceuticals in Q4 2015 and held it in 40 quarters.
- Bank of America's Titan Pharmaceuticals position peaked at $222K in Q3 2016.
- 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2025.
Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.